FRESENIUS KABI, LLC
- LAKE ZURICH, IL 60047
- fresenius-kabi.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 11, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $155.7M
- Awards on record
- 1,604
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
FRESENIUS KABI, LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About FRESENIUS KABI, LLC
- Headquarters
- LAKE ZURICH, IL 60047
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIC2TRNWNQKMD6
- CAGE57KZ6
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $155.7M
- Awards on record
- 1,604
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response · Defense Logistics Agency
25 most recent of 1,604 awards
75A50325C00004
Recompete 18+ mo: Potential end Mar 13, 2030 (39 months away)BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $111.7M
- Period of performance
- Mar 14, 2025 – Mar 13, 2030
75A50326C00007
Recompete 6–12 mo: Potential end Sep 29, 2027 (10 months away)PROCUREMENT OF PHARMACEUTICALS - DOXYCYCLINE, SODIUM CHLORIDE, AND METHYLPREDNISOLONE
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $24.4M
- Period of performance
- Sep 30, 2026 – Sep 29, 2027
SPE2D026F0278
Recompete 6–12 mo: Potential end Aug 30, 2027 (9 months away)8512244166!OTHER MEDICAL
Department of Defense · Defense Logistics Agency
- Obligated
- $1.3M
- Period of performance
- Jul 20, 2026 – Aug 30, 2027
75A50326F80006
Recompete 6–12 mo: Potential end Jul 29, 2027 (8 months away)ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ., 5MG/ML, MULTI-DOSE VIALS EO 14398
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $7.9M
- Period of performance
- Jul 30, 2026 – Jul 29, 2027
SPE2D025F0535
Completed: Period of performance ended Aug 31, 20268511525788!OTHER MEDICAL
Department of Defense · Defense Logistics Agency
- Obligated
- $1.4M
- Period of performance
- Jul 24, 2025 – Aug 31, 2026
SPE2D326F286Q
Completed: Period of performance ended Jul 23, 20264572525174!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $426.3
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F286S
Completed: Period of performance ended Jul 23, 20264572511904!GENTAMICIN 80 MG/2 ML VIAL 2ML
Department of Defense · Defense Logistics Agency
- Obligated
- $68.8
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F286X
Completed: Period of performance ended Jul 23, 20264572477768!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $639.4
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F286Y
Completed: Period of performance ended Jul 23, 20264572477178!ATROPINE 8 MG/20 ML VIAL 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $74.3
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F282G
Completed: Period of performance ended Jul 22, 20264572442000!CALCIUM GLUC 1,000 MG/10 ML VL 10ML
Department of Defense · Defense Logistics Agency
- Obligated
- $154.6
- Period of performance
- Jul 21, 2026 – Jul 22, 2026
SPE2D326F285S
Completed: Period of performance ended Jul 22, 20264572444934!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $106.6
- Period of performance
- Jul 21, 2026 – Jul 22, 2026
SPE2D326F285W
Completed: Period of performance ended Jul 22, 20264572444936!XYLOCAINE 1%-EPI 1:100,000 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $402.6
- Period of performance
- Jul 21, 2026 – Jul 22, 2026
SPE2D326F275T
Completed: Period of performance ended Jul 21, 20264572441999!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $213.1
- Period of performance
- Jul 20, 2026 – Jul 21, 2026
SPE2D326F277S
Completed: Period of performance ended Jul 21, 20264572431868!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $426.3
- Period of performance
- Jul 20, 2026 – Jul 21, 2026
SPE2D326F277U
Completed: Period of performance ended Jul 21, 20264572432649!XYLOCAINE 1%-EPI 1:100,000 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $80.5
- Period of performance
- Jul 20, 2026 – Jul 21, 2026
SPE2D326F279X
Completed: Period of performance ended Jul 21, 20264572442001!VANCOMYCIN 1 GM VIALS
Department of Defense · Defense Logistics Agency
- Obligated
- $159.3
- Period of performance
- Jul 20, 2026 – Jul 21, 2026
SPE2D326F273M
Completed: Period of performance ended Jul 20, 20264572431065!XYLOCAINE 1%-EPI 1:100,000 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $80.5
- Period of performance
- Jul 17, 2026 – Jul 20, 2026
SPE2D326F268D
Completed: Period of performance ended Jul 16, 20264572391872!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $213.1
- Period of performance
- Jul 15, 2026 – Jul 16, 2026
SPE2D326F268H
Completed: Period of performance ended Jul 16, 20264572391871!XYLOCAINE 1%-EPI 1:100,000 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $241.5
- Period of performance
- Jul 15, 2026 – Jul 16, 2026
SPE2D326F268X
Completed: Period of performance ended Jul 16, 20264572391870!ATROPINE 8 MG/20 ML VIAL 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $37.2
- Period of performance
- Jul 15, 2026 – Jul 16, 2026
SPE2D326F258W
Completed: Period of performance ended Jul 15, 20264572378589!DEXAMETHASONE 120 MG/30 ML VL 30ML
Department of Defense · Defense Logistics Agency
- Obligated
- $115.4
- Period of performance
- Jul 14, 2026 – Jul 15, 2026
SPE2D326F260B
Completed: Period of performance ended Jul 15, 20264572378591!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $2.6K
- Period of performance
- Jul 14, 2026 – Jul 15, 2026
SPE2D326F256L
Completed: Period of performance ended Jul 14, 20264572378594!ATROPINE 8 MG/20 ML VIAL 20ML
Department of Defense · Defense Logistics Agency
- Obligated
- $37.2
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
SPE2D326F256N
Completed: Period of performance ended Jul 14, 20264572378596!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $639.4
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
SPE2D326F257A
Completed: Period of performance ended Jul 14, 20264572378598!KETOROLAC 30 MG/ML VIALML
Department of Defense · Defense Logistics Agency
- Obligated
- $106.6
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75A50325C00004 BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $111.7M | Mar 14, 2025 – Mar 13, 2030 | Recompete 18+ mo: Potential end Mar 13, 2030 (39 months away) |
75A50326C00007 PROCUREMENT OF PHARMACEUTICALS - DOXYCYCLINE, SODIUM CHLORIDE, AND METHYLPREDNISOLONE | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $24.4M | Sep 30, 2026 – Sep 29, 2027 | Recompete 6–12 mo: Potential end Sep 29, 2027 (10 months away)AI brief for award 75A50326C00007Bid team for the recompete of award 75A50326C00007 |
SPE2D026F0278 under SPE2D020D0009 8512244166!OTHER MEDICAL | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $1.3M | Jul 20, 2026 – Aug 30, 2027 | Recompete 6–12 mo: Potential end Aug 30, 2027 (9 months away)AI brief for award SPE2D026F0278Bid team for the recompete of award SPE2D026F0278 |
75A50326F80006 under 36F79725D0145 ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ., 5MG/ML, MULTI-DOSE VIALS EO 14398 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $7.9M | Jul 30, 2026 – Jul 29, 2027 | Recompete 6–12 mo: Potential end Jul 29, 2027 (8 months away)AI brief for award 75A50326F80006Bid team for the recompete of award 75A50326F80006 |
SPE2D025F0535 under SPE2D020D0009 8511525788!OTHER MEDICAL | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $1.4M | Jul 24, 2025 – Aug 31, 2026 | Completed: Period of performance ended Aug 31, 2026 |
SPE2D326F286Q under SPE2D020D0009 4572525174!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $426.3 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F286S under SPE2D020D0009 4572511904!GENTAMICIN 80 MG/2 ML VIAL 2ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $68.8 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F286X under SPE2D020D0009 4572477768!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $639.4 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F286Y under SPE2D020D0009 4572477178!ATROPINE 8 MG/20 ML VIAL 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $74.3 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F282G under SPE2D020D0009 4572442000!CALCIUM GLUC 1,000 MG/10 ML VL 10ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $154.6 | Jul 21, 2026 – Jul 22, 2026 | Completed: Period of performance ended Jul 22, 2026 |
SPE2D326F285S under SPE2D020D0009 4572444934!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $106.6 | Jul 21, 2026 – Jul 22, 2026 | Completed: Period of performance ended Jul 22, 2026 |
SPE2D326F285W under SPE2D020D0009 4572444936!XYLOCAINE 1%-EPI 1:100,000 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $402.6 | Jul 21, 2026 – Jul 22, 2026 | Completed: Period of performance ended Jul 22, 2026 |
SPE2D326F275T under SPE2D020D0009 4572441999!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $213.1 | Jul 20, 2026 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
SPE2D326F277S under SPE2D020D0009 4572431868!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $426.3 | Jul 20, 2026 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
SPE2D326F277U under SPE2D020D0009 4572432649!XYLOCAINE 1%-EPI 1:100,000 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $80.5 | Jul 20, 2026 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
SPE2D326F279X under SPE2D020D0009 4572442001!VANCOMYCIN 1 GM VIALS | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $159.3 | Jul 20, 2026 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
SPE2D326F273M under SPE2D020D0009 4572431065!XYLOCAINE 1%-EPI 1:100,000 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $80.5 | Jul 17, 2026 – Jul 20, 2026 | Completed: Period of performance ended Jul 20, 2026 |
SPE2D326F268D under SPE2D020D0009 4572391872!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $213.1 | Jul 15, 2026 – Jul 16, 2026 | Completed: Period of performance ended Jul 16, 2026 |
SPE2D326F268H under SPE2D020D0009 4572391871!XYLOCAINE 1%-EPI 1:100,000 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $241.5 | Jul 15, 2026 – Jul 16, 2026 | Completed: Period of performance ended Jul 16, 2026 |
SPE2D326F268X under SPE2D020D0009 4572391870!ATROPINE 8 MG/20 ML VIAL 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $37.2 | Jul 15, 2026 – Jul 16, 2026 | Completed: Period of performance ended Jul 16, 2026 |
SPE2D326F258W under SPE2D020D0009 4572378589!DEXAMETHASONE 120 MG/30 ML VL 30ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $115.4 | Jul 14, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
SPE2D326F260B under SPE2D020D0009 4572378591!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $2.6K | Jul 14, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
SPE2D326F256L under SPE2D020D0009 4572378594!ATROPINE 8 MG/20 ML VIAL 20ML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $37.2 | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
SPE2D326F256N under SPE2D020D0009 4572378596!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $639.4 | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
SPE2D326F257A under SPE2D020D0009 4572378598!KETOROLAC 30 MG/ML VIALML | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $106.6 | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 424210Title not in the curated listPrimary
- 325412Pharmaceutical Preparation Manufacturing
- 423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- 6505DRUGS AND BIOLOGICALS
- 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- 6545REPLENISHABLE FIELD MEDICAL SETS, KITS, AND OUTFITS
- 6640LABORATORY EQUIPMENT AND SUPPLIES
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 11, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with FRESENIUS KABI, LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
